Scientists identify new genes responsible for four serious mental illnesses

Published: Comments:
Community Health & Wellness Science & Research


Researchers have identified 70 previously unknown genes that contribute to people developing the serious mental health disorders schizophrenia, bipolar disorder, depression and Attention Deficit Hyperactivity Disorder (ADHD).

The findings have been published today in the prestigious journal Nature Genetics. The study was led by the head of QIMR Berghofer’s Translational Neurogenomics Group, Professor Eske Derks, in collaboration with scientists from Vanderbilt University and the University of Amsterdam. 

Professor Derks said her team also identified how the activity, or expression, of those 70 new genes, and 261 other genes that were already linked to mental illnesses, increased the disease risk.

There is a growing body of evidence that genetic risk factors and environmental triggers such as stress and trauma can cause schizophrenia, bipolar disorder, depression and ADHD.

“In this study we are homing in on the biological causes of these mental illnesses,” Professor Derks said.

The researchers examined data from tens of thousands of people collected from four separate studies into schizophrenia, bipolar disorder, depression and ADHD and compared it to information from hundreds of thousands of healthy controls who were classified as not having mental illnesses.

“For schizophrenia for example we looked at the genetic data from about 40,000 patients and compared it to data from about 65,000 control samples from people without the disorder,” she said.

“Through this process we identified 275 genes whose activity levels contribute to the risk of schizophrenia, 13 genes whose expression is associated with bipolar disorder, 31 genes involved in depression and 12 for ADHD. We can now conduct follow up tests of those particular genes.”

The study also looked at the DNA and gene activity, or expression, in brain, colon, adrenal gland and whole blood tissue samples from 700 deceased donors who had not been diagnosed with psychiatric disorders during their lives, to gain an understanding of where in the body the gene activity was taking place.

“This extra level of inquiry proved very valuable because 137 of the 331 genes (41 per cent) were found solely in brain tissue while only 24 per cent of the genes were detected in the easily accessible blood tissue,” Professor Derks said.

“This study narrows the field on which genes contribute to these four serious mental disorders.

“Recent studies have found associations between the disorders and large regions of the genome, but they didn’t reveal which particular genes were responsible or how the genes’ activity affected the risk of developing a mental illness.

“We pinpointed a smaller set of genes and looked at how much their level of expression in different tissues such as brain, colon, adrenal gland, and blood, contributed to symptoms.

“This study provides more evidence about the genetic basis of these diseases and by better understanding the biology of the genes, attention can turn to finding the best drugs or treatments to manage them.

“It’s not enough that we know that gene X is involved in a disease, we need to know exactly what it is doing. Is it too active or not active enough and how do we change its level of activity to prevent or even
stop symptoms?

“We’ll now be working on exploring drug repurposing – to see if any existing drugs that have already been approved for human use can act on any of these genes or combination of genes.

“Also, importantly, this study has again confirmed that genetics, along with environmental risk factors, influence the possibility of developing these mental health disorders and adds weight to the need for
more genetic research to better understand why some people are more vulnerable to developing mental illness.”

Professor Derks said she hoped to use the same approach of integrating genetic and gene expression data in the future to understand which genes are responsible for other psychiatric disorders such as obsessive compulsive disorder, substance abuse, anorexia and other eating disorders.

QIMR Berghofer Medical Research Institute :
PO Royal Brisbane Hospital, Brisbane, QLD, 4029, Brisbane
07 3845 3752
QIMR Berghofer Medical Research Institute
Showing 10+ recent articles for this business
Australian pilots not at higher risk of Melanoma 21 May 2019 | A new study has found modern airline pilots registered in Australia, appear not to be at higher risk of developing invasive melanoma than the rest of the population. More information...
Study finds being overweight is likely to cause cancer 16 May 2019 | A QIMR Berghofer study has found people who are overweight could reduce their risk of dying from cancer later in life by up to 30 per cent, by shedding some kilograms and maintaining a healthy body mass index... More information...
Scientists identify new genes responsible for four serious mental illnesses 14 May 2019 | Researchers have identified 70 previously unknown genes that contribute to people developing the serious mental health disorders schizophrenia, bipolar disorder, depression and Attention Deficit Hyperactivity... More information...
Blood test could help guide treatment for some breast cancer patients 29 April 2019 | QIMR Berghofer researchers have discovered why some triple negative breast cancer patients do not respond to a common chemotherapy drug and say a simple blood test could help determine the best treatment. More information...
Scientists find link between age and different subtypes of bowel cancer 18 April 2019 | A study by QIMR Berghofer Medical Research Institute has for the first time identified that bowel cancer has five distinct subtypes that are closely related to a patient’s age. More information...
Scientists use thousands of miniature hearts to test potential new drugs 29 March 2019 | Australian scientists have conducted the first ever screening of potential heart regeneration drugs using bioengineered human heart muscle – a move that could revolutionise how heart drugs are developed in the... More information...
Aspirin and similar drug use linked to lower endometrial cancer risk in overweight women 07 March 2019 | A study by QIMR Berghofer researchers has found that overweight and obese women who take aspirin at least once a week may reduce their risk of developing endometrial cancer (cancer of the womb). More information...
Safer bone marrow transplants for blood cancer patients a step closer 15 February 2019 | Queensland researchers have conducted Australia’s first clinical trial using genetically engineered immune cells to make bone marrow transplantation for blood cancer safer. More information...
New study finds hysterectomies reduce the risk of ovarian cancer in some women 12 February 2019 | A new study by QIMR Berghofer researchers has found women who suffer from endometriosis or uterine fibroids and who undergo hysterectomies have a significantly lower risk of developing ovarian cancer than those... More information...
Australia’s melanoma rates once again highest in the world 07 February 2019 | Australia has regained the unenviable title of having the world’s highest rates of invasive melanoma. More information...

comments powered by Disqus

All articles submitted by third parties or written by My Sunshine Coast come under our Disclaimer / Terms of Service